Jumoke Kolawole and her family fled for their lives and arrived in the U.S. with what they could fit in their suitcases. Having been torn away from her friends, family and home, Jumoke found herself struggling to adapt to the pressures of building a new life in a new world where she was surrounded by the unfamiliar and further isolated by the pandemic. That’s when her depression overwhelmed her. This is Jumoke’s story of breaking through the stigma and finding help and healing. If you or a loved one is seeking mental health treatment or additional information on mental health, visit our website at NAMI.org. Call our HelpLine at 1-800-950-NAMI (6264) – open Mon-Fri from 10 a.m. to 10 p.m. ET Text “NAMI” to 741-741 – Available 24/7 Visit us online at nami.org. Find your local NAMI at nami.org/findsupport NAMI, the National Alliance on Mental Illness, is the nation’s largest grassroots mental health organization dedicated to building better lives for the millions of Americans affected by mental illness.
NAMI Ending the Silence (ETS) is a 50-minute interactive presentation that helps teens learn about the warning signs of mental health conditions and what steps they should take to find support for themselves or their friends.
NAMI Ask the Expert Webinar welcomes Robert O. Cotes, M.D., Director of the Clinical & Research Program for Psychosis at Grady Health, Emory University School of Medicine, who discusses the unique and potentially life-changing benefits of clozapine, an antipsychotic medication used to treat symptoms of schizophrenia. Currently, the American Psychiatric Association guidelines recommend a trial of clozapine if a person still has symptoms despite two prior trials of other antipsychotic medications. However, despite its effectiveness, clozapine is underutilized in the U.S. and often treated as a “last resort” option. In this presentation, Dr. Cotes helps individuals and families better understand clozapine’s benefits, side effects and recent changes to the FDA’s Risk Evaluation and Mitigation Strategy regarding the drug.